Here are five points:
1. Florida changed its requirements in 2011, forbidding physicians from dispensing Schedule II and Schedule III opioids.
2. Although Florida made substantial efforts to address opioid abuse, the American Medical Association discovered Florida’s reform resulted in a mere 1.4 percent decrease in opioid prescriptions and a 2.5 percent decrease in opioid volume.
3. Still, the ban forced many physicians to prescribe more nonsteroidal anti-inflammatory drugs.
4. Many states that have implemented reform focus on the price, which limits reimbursements.
5. To date, 14 states have made changes based solely on cost reduction, according to WCRI.
More articles on quality:
University of Pittsburgh Medical Center, Health Catalyst to collaborate: 4 insights
Infectious diseases continues to be a major issue for elderly adults — 7 things to know
Anthem Blue Cross and Blue Shield, Ohio Independent Collaborative launch patient-centered arrangement — 4 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
